Altimmune, Inc. (ALT) Tops Q4 EPS by 7c

Altimmune, Inc. (NASDAQ: ALT) reported Q4 EPS of ($0.43), $0.07 better than the analyst estimate of ($0.50).

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• AI and earnings keep driving markets as focus shifts to Trump-Xi summit
• UBS Reiterates Neutral Rating on Pilgrim's Pride (PPC) on 'Challenging' Near-Term Fundamentals
• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance